Day 1 :
Keynote Forum
Reza Nassiri
Michigan State University
USA
Keynote: Emerging antibiotic resistance: A threat to modern medicine
Time : 09:20-09:50

Biography:
Dr. Nassiri is a former Associate Dean of Global Health at the Michigan State University (MSU). He also served as MSU director of Institute of International Health. He is currently Professor of Pharmacology and Toxicology, Professor of Family and Community Medicine, and, lecturer in Global Health, Infectious Diseases and Tropical Medicine. He currently works on international public health issues relating to chronic diseases and has expertise in global health. He has made contributions in various fields of medical sciences including clinical investigation and health education. On the basis of his extensive experience and expertise in chronic infectious diseases including HIV/AIDS, TB as well as antimicrobial resistance and human gut microbiome, he developed clinical research programs in Brazil, South Africa, Haiti, Dominican Republic and Mexico.
Abstract:
Global consumption of antibiotics has increased nearly 40% in the last decade. The incredible rapid resistance of antibiotic resistance which is taking place worldwide is not only a serious threat to the practice of modern medicine, but equally important, a threat to global public health. This urgent issue is so alarming that it caught the attention of G-20 Summit in both China (2016) and Germany (2017), let alone the U.N. Assembly in 2016 had called for a special meeting of “superbugs” which focused on the escalating drug resistance with respect to the sexually transmitted disease gonorrhea and carbapenem resistant Enterobacteriaceae. While the causes of antibiotic resistance are complex, certainly human behavior play a significant role in the spread of antibiotic resistant genes. In addition to the human behavior, the drivers of resistance include agriculture sector, animal husbandry, household and industry – these factors contribute significantly to the spread of the resistant genes within the ecosystem. Such resistant mechanisms are continuously emerging globally, which threatens our ability to treat common infections, resulting in increased death, disability and costs. Since the development and clinical use of penicillins, nearly 1000 resistant-related beta-lactamases that inactivate various types of antibiotics have been identified. There is also a global concern about the emergence of antibiotic resistant carried by the healthy individuals, the commensal bacteria. The CDC and WHO surveillance data shows that the resistance in E. coli is generally and consistently the highest for antibacterial agents in both human and veterinary medicine. Within communities, resistant bacteria circulate from person to person or from animals and environment to person, or vice versa. With 1 billion people travelling each year, bacteria is becoming more mobile. The bacterial resistance can kill 700,000 worldwide each year and it’s been estimated to kill 10 million by 2050. The WHO estimates 78 million people a year get gonorrhea, an STD that can infect the genitals, rectum and throat - there is a widespread resistance to the first-line medicine ciprofloxacin as well as increasing resistance to azithromycin. The emergence of resistance to last-resort treatments known as extended-spectrum cephalosporins (ESCs) is now eminent. The five riskiest superbugs are recognized as (1) the original one: Staphylococcus Aureus (MRSA), (2) the hospital lurkers: Clostridium Difficile and Acinetobacter, (3) the food borne pathogens: Escherichia Coli and Salmonella, (4) The sexually-transmitted infections: Gonorrhea and Chlamydia, and (5) TB. India is a typical example of encountering the deadly bacterial resistance. The discovery of the New Delhi metallo-beta-lactamase-1 (NDM-1) which disables almost all antibiotics directed against it, was turning point in the rapid emergence of blaNDM-1 gene which was first identified in 2008 in people who had traveled in India or sought medical care in South Asia. The gene for NDM-1 travels on a plasmid, an extra-chromosomal loop of DNA that can be traded freely among bacteria. So far, it has been found a variety of bacterial species that carry NDM-1 particularly in the gut bacteria, can cause serious infections in vulnerable hospital patients in India, South Asia, South Africa and the UK. There are two major routes of spread for the bacteria; hospital and the community. In hospital infections, bacteria carrying NDM-1 move from person to person when patients who have received many antibiotics, develop diarrhea and traces of feces contaminate surfaces, equipment and healthcare workers' hands. In community infections, the bacteria carrying the enzyme passes from person to person when traces of feces contaminate municipal water supplies – and with a large percentage of the population lacking any access to sanitation. Public Health Foundation of India believes that 60,000 infants per year are dying of drug-resistant infections due to NDM-1. In addition, tourists can pick up antibiotic-resistance genes in just 2-3 days. Currently, India is facing with two antibiotic resistant genes what carry NDM-1; E. coli and Klebsiella. The discovery mrc-1 gene in China which is being transferred between Klesbsiella pneumoniae and E. Coli further compounded the global burden of antibiotic resistance, which has already spread to the neighboring countries. In the animal husbandry and agricultural sectors of China, the demand for the antibiotics to reach almost 12,000 tons per year. The high prevalence of the mrc-1 gene in E. Coli samples both in animals and raw meat, with the number of positive-testing samples are increasing each year in China. On average, more than 20 percent of bacteria in the animal samples and 15 percent of the raw meat samples carried the mrc-1 gene. Numerous European countries have reported the existence of mrc-1 gene in the isolates from human, isolates from animals used for food, isolates from food, and isolated from the environment. In conclusion, pathogens rapidly develop mutations that render current treatments ineffective – resistance to carbapenems, one of the ‘last lines’ of antibiotics, is widespread and has been observed in numerous countries. Therefore, there is an urgent need between research universities and industry aimed at developing novel antimicrobial agents to save the practice of modern medicine.
Keynote Forum
Thierry Troussier
Head of UNESCO Chair Sexual Health & Human Rights, Paris Diderot University, France
Keynote: Why it is important to integrate the SDGs in a sexual and reproductive health education to improve the HIV and STIs results and to achieve the SDGs?
Time : 09:50-10:20

Biography:
Head of UNESCO Chair sexual health & Human rights, and Public health professor in Paris Diderot University
Abstract:
Keynote Forum
Kristine McCluskey
Baylor College of Medicine Texas, USA
Keynote: Zika virus tissue sampling protocol’s purpose defined through algorithm in anatomic pathology for trainees
Time : 10:35-11:05

Biography:
Abstract:
Keynote Forum
Sharwani Vijayshree Lal
Dr. Ram Manohar Lohia Hospital, India
Keynote: Profile of opportunistic infections in patients with HIV/AIDS started on ART & its correlation with CD4 cell counts
Time : 11:05-11:35

Biography:
Abstract:
Keynote Forum
Natalie Borg
Monash University
Australia
Keynote: Characterization of hendra virus V protein interactions with human nuclear transport receptors reveals opportunities to target hendra virus infection
Time : 11:35-12:05

Biography:
Natalie Borg has completed her PhD from the University of Melbourne and postdoctoral studies from Monash University Department of Biochemistry and Molecular Biology. She is an ARC Future Fellow and Heads the Immunity and Infection Laboratory at the leading Australian University, Monash University. She has published 29 papers in premier journals including Nature and Nature Structural and Molecular Biology.
Abstract:
Keynote Forum
Kristina M. Miller
Fisheries and Oceans
Canada
Keynote: Molecular indices of viral disease development applied to discover emerging disease etiology
Time : 12:05-12:35
Biography:
Abstract:
Climate change enhances vulnerability of organisms to stress and disease, which can result in volatility in survival and ultimately population decline for many species. Emerging infectious diseases have been resolved in some cases, but understanding their disease etiology can be difficult in instances where morbidity and mortality are not readily observable. Sensitive technologies to detect early stages of disease development in live-sampled organisms, and the ability to differentiate pathogen carrier states from active disease states are required to demonstrate impacts of infectious diseases in wild populations. We present the discovery and validation of host transcriptional biomarkers capable of distinguishing the presence of an active viral disease state (VDD) from latent viral infections, and viral versus bacterial disease states in salmon. Biomarker discovery was conducted through meta-analysis of published and in-house microarray data, and validation performed on independent datasets including disease challenge studies and farmed diagnoses of various viral, bacterial, and parasitic diseases. We demonstrate that the VDD biomarker panel is predictive of disease development across RNA-viral species, salmon species, and salmon tissues, and can recognize a viral disease state in cultured and wild-migrating salmon. Application of this technology has led to the discovery of eight novel salmon viruses in British Columbia alone. Biomarkers resolved in our study on salmon were highly overlapping with those based on similar human viral influenza research, suggesting a highly conserved suite of host genes associated with viral disease that may be applicable across a broad range of vertebrate taxa.
- Recent Emerging Diseases
Sexually Transmitted Infectious Diseases
Pediatric Infectious Diseases
Diagnostic Tools
Recent Emerging Diseases
Sexually Transmitted Infectious Diseases
Pediatric Infectious Diseases
Diagnostic Tools
Location: Zurich, Switzerland

Chair
Reza Nassiri
Michigan State University
USA

Co-Chair
Qingzhong Kong
Case Western Reserve University
USA
Session Introduction
Qingzhong Kong
Case Western Reserve University School of Medicine
USA
Title: Zoonotic risk of chronic wasting disease prions in cervids: From animal models to human studies

Biography:
Abstract:
Maria José Figuera
University Rovira i Virgili
Spain
Title: Aeromonas a negelected emerging old microbe that keeps on producing life threatening infections

Biography:
Abstract:
- Vector Borne Infections
Microbial Genomics
Host and Microbial Genetics
HIV/AIDS
Diagnostic Tools for Immunological and Virological Monitoring of HIV Infection
Location: Zurich, Switzerland

Chair
Shih-Yen Chen
Taipei Medical University, Shuang Ho Hospital
Taiwan

Co-Chair
Dibyendu Banerjee
Calcutta National Medical College, India
Session Introduction
Sheikh Ajaz Rasool
Jinnah University for Women
Pakistan
Title: Evolution of super-drug resistant microbial strains: Mechanisms and strategies for containment

Biography:
Abstract:
Lisa Becherer
University of Freiburg
Germany
Title: Simultaneous detection of HIV and HTLV by mediator displacement loop-mediated isothermal amplification

Biography:
Abstract:
Nucleic acid amplification tests (NAAT) are not only a powerful tool for early diagnosis of HIV infections, NAAT are also a reliable method for HIV viral load measurements during the monitoring of antiretroviral therapy. Additionally, NAAT allow simultaneous (multiplex) detection of different targets enabling the detection of HIV/HTLV co infections. Loopmediated isothermal amplification (LAMP) [1, 2] emerges as a convenient alternative to polymerase chain reaction (PCR) for rapid amplification of target DNA and RNA. As an isothermal NAAT, LAMP does not require expensive equipment for thermo cycling and is therefore especially suitable for point-of-care testing [3]. However, available multiplex detection techniques for LAMP suffer from elaborate assay design as well as time-consuming optimization work. Here we present the first multiplex reverse transcription (RT) LAMP for identification of HIV/HTLV co-infections [4]. The quantitative real-time assay is based on universal mediator and reporter molecules [5] generating a fluorescence signal in the presence of target sequences. During amplification of target DNA the mediator is displaced (step 1, Figure 1). The released mediator hybridizes to the reporter generating a fluorescence signal (step 2, Figure 1) which can be detected.
Sharwani Vijayshree Lal
Dr. Ram Manohar Lohia Hospital
India
Title: A rare case of zidovudine induced lactic acidosis with pancreatitis and myopathy

Biography:
Sharwani Vijayshree Lal is currently working as a Medical Officer at a Central Government Hospital in the capital of India. She has developed sharp acumen and insight in effective clinical judgement. Her passion for meticulous and comprehensive management of a case has matured during her rewarding exposure to healthcare in hospitals and educational institutions over the years. This study, capturing profile of opportunistic infections in patients with HIV, effectively demonstrates the significance of sound assessment and diligent handling of a case.
Abstract:
Shih-Yen Chen
Taipei Medical University, Shuang Ho Hospital
Taiwan
Title: A rare case of zidovudine induced lactic acidosis with pancreatitis and myopathy Clinical characteristics and viral shedding of children with norovirus gastroenteritis

Biography:
Abstract:
Dibyendu Banerjee
Calcutta National Medical College
India
Title: Acinetobacter to target organ: Is biofilm the missing link?

Biography:
Abstract:
Usman Lodhi
Provincial Tuberculosis Control Program
Pakistan
Title: Treatment outcomes and their association with type of resistance among drug resistant tuberculosis patients during 2014-2015 in Punjab, Pakistan: A retrospective cohort analysis

Biography:
Abstract:
Kristina M. Miller
Fisheries and Oceans Canada
Title: Unravelling the common etiology of related, but pathologically divergent diseases
Biography:
Abstract:
Paulo Antonio Rodrigues Gouveia
Mutamba MGU Brazil
Title: Therapeutic use of Guazulma ulmifolia lam extract of Northern Brazil
Time : 16:40-17:30
Biography:
Abstract:
Nebiyu Lera Alaro
Texila American University Guyana Kenya
Title: Challenges faced by healthcare providers in providing services to key population at risks of HIV in Ethiopia
Biography:
Nebiyu Ler Alaro is a graduate of Texila America University Guyana PHD Public Health 2018 July. He took up Education as a career after majoring in Nursing. He completed Master’s education 2015 and starting PHD Public Health 2016. I am currently living and working South Sudan Doctors with Africa CUAMM as Health Project Manager.
Abstract:
- Modern and Unique Diagnostics
Veterinary Infectious Diseases
Advancements in Vaccines and Therapeutics
HIV/AIDS
Location: Zurich, Switzerland

Chair
Thierry Troussier
Head of UNESCO Chair Sexual Health & Human Rights Paris Diderot University, France

Co-Chair
Hiroshi Ohrui
Yokohama University of Pharmacy, Japan
Session Introduction
Hiroshi Ohrui
Yokohama University of Pharmacy Japan
Title: EFdA: A very excellent anti-HIV modified nucleosides - from design to the current results of clinical trials

Biography:
Abstract:
Eunwoo Yoo
Sheikh Khalifa Specialty Hospital, UAE
Title: The effectiveness of a covert observational study in improving the hand hygiene compliance

Biography:
Abstract:
Background: Covert observation (CO) is a useful method as an effective and direct observation of hand hygiene (HH) compliance monitoring to overcome the Hawthorne effect. However, it is not clear whether the CO is effective in improving HH compliance. Accordingly, we conducted a study to determine the impact of covert observation on HH compliance. Method: We designed a prospective interventional study. Trained mystery shoppers monitored the entry and exit HH compliances in 3 different phases; the first CO (f-CO) in March and May 2017, CO combined with just-in-time coach (JITC) in July and October 2017, and second CO phases without JITC (s-CO) in March 2018. Overt observations (OO) were done simultaneously with above three phases by the infection control link personnel. We used Hand Hygiene Targeted Solutions Tool® for data collection. Results: Total of 10857 opportunities for HH were observed (3473 for f-CO, 2800 for JITC, and 1807 for s-OC) including 2777 opportunities for OO. The HH compliance rate of OO was 91.0% (2577/2777). HH compliance rate of f-CO was 34.3% (1192/3473). The rate was increased to 62.7% (1756/2800) by JITC (p=.00). HH compliance rate of s-CO was decreased to 57.5% (1039/1807) again but was still higher than the rate of f-CO (p=.00). HH rates on the exit opportunities were higher than the entry in all observations (89.7% (1257/1401) versus 92.3% (1270/1376) (p=.02), 31.5% versus 37.6%, 57.0% versus 69.0%, and 51.9% versus 62.9% for OO, f-CO, JITC, and s-CO respectively). Conclusions: CO method was useful for minimizing Hawthorne effect. However, CO was not effective for improving the HH compliance rate without the real-time feedback (JITC). Repeated JITC along with monitoring is needed to improve and maintain the good HH compliance.
Naser Shahabinejad
Kerman University of Medical Sciences Iran
Title: Dengue fever serology in febrile patient in Southeast Iran
Time : 11:55-12:15

Biography:
Abstract:
Francis Oronsaye
Science University of Benin Nigeria
Title: Treatment of an emerging disease using a new lotion (Oronsfranklo) ®
Time : 12:15-12:35

Biography:
Abstract:
Juan Pablo Loureiro
National University of La Plata Argentina
Title: Tuberculosis in marine mammals: Is it an emerging disease?

Biography:
Abstract:
The rehabilitation center of Mundo Marino´s Foundation attended 2008 marine mammals, founded on the northern coast of Buenos Aires province (36° 22'S/56° 44' W to 37° 15'S/56° 58 W) from 1987 to date. Among the most frequently attended marine mammals there were: 1315/2008 (65, 49%) South American sea lions (Arctocephalus australis); 113/2008 (6, 59%) sub-Antarctic sea lions (Arctocephalus tropicalis) and 159/2008 (9, 27%) South American fur seals (Otaria flavescens). In 1983, the necropsy of an A. australis showed macroscopic lesions compatible with tuberculosis and this finding was the starting of a research project on this disease. On February 27, 1989, an adult female A. australis, weighing 40 kg, was rescued with signs of dyspnea, weakness, permanent ventral recumbency and poor physical condition. Despite medical care the animal died. Necropsy showed lung and lymphatic lesions compatible with tuberculosis. Bacteriological cultures and molecular biology of samples were collected and we could identify a new member of Mycobacterium tuberculosis complex: named Mycobacterium pinnipedii. The 2.17% of pinnipeds admitted into the rehabilitation center were diagnosed with tuberculosis. Isolates of mycobacteria strains from sea lions have shown to have in vitro sensitivity to the tuberculostatic drugs isoniazid, streptomycin, rifampin, ethambutol and paraminosalicylic acid. As the diagnosis of the diseases of the animals admitted to the rehabilitation center was being perfected, undescribed diseases were found. This situation makes it difficult to determine if they are emerging diseases or they already existed in nature.
Ferdoshe Akter
Ministry of Fisheries and Livestock Bangladesh
Title: Surgical correction of ventral abdominal hernia in pigeon- 3

Biography:
Abstract:
Gossips of typical umbilical hernia are habitually described in ruminants but poetries are not available in ventral abdominal hernia in birds specially, in pigeon. Abdominal hernias have been characterized as a separation in the aponeurosis of the abdominal musculature on the ventral midline. The purpose of this case report is to give an overview about the diagnosis and surgical approach of ventral abdominal hernia in pigeons. Three male king breed pigeons of different ages (5 months – 10 months) and weights (250 g – 600 g) were presented to Upazila livestock office & veterinary hospital, Chakaria, Cox's Bazar from January 2016 to March 2018 with the common history of gradual swelling in the ventral abdominal region. Clinical and radiographic examination confirmed the ventral abdominal hernia and decided for surgical correction. With standard aseptic procedure and 1% lidocaine anaesthesia, coeliotomy was performed in all cases. Postoperatively antibiotic, cefixime was administered for 5 days at the dose rate of 30 mg/kg body weight and monitored until wound healing. The follow up study for one month revealed no complications. The result of this case study recommends that this approach can be used as a curative method for ventral abdominal hernia repair in pigeon.
Mohammad Effat
National Research Centre Egypt
Title: Severe recurrent Vulvovaginal candidiasis caused by mixed Candida species

Biography:
Abstract:
It is not infrequent for every woman during her different stages of life to catch a vulvovaginal candidiasis (VVC) and has to visit a gynecologist suffering from pelvic pain accompanied by itching, creamy white vaginal discharges, burning sensation, dyspareunia (if married) and redness and swelling of external genitalia. A 37 years old married woman used to intake a lot of antibacterial agents for her refractory periodontitis, has been frequently suffering from the above mentioned symptoms for three years. She received many types of commercially available antifungal agents without any improvement. She delivered two higher vaginal swabs for performing culture and sensitivity. Direct microscopic examination of the wet sample revealed yeast and filamentous forms of Candida. Gram staining showed violet round to oval colonies with budding. Direct cultivation on Sabouraud dextrose agar (SDA) revealed very small pale white colonies. CHROMagar plates streaked with the grown colonies from SDA showed two different colored colonies (green; G and rose; R). Germ tube test for G and R colonies was separately done and germ tube formation appeared only with G colonies. Rice extract agar test performed for G and R colonies separately revealed chlamydospores (terminal) formation only with G colonies. API 20 C AUX used for G and R colonies separately, showed Candida albicans (99.3%) and Candida krusei (85.8%) respectively. Upon carrying out in vitro antifungal susceptibility test, Candida krusei colonies were sensitive to nystatin and fluconazole however, Candida albicans colonies were sensitive to nystatin but resistant to fluconazole. This case of mixed infection of VVC was very difficult to be treated with the commercially available fluconazole alone and there is no available systemic nystatin.
Saroj Yadav
Chittagong Veterinary and Animals Science University Bangladesh
Title: Molecular study of Cryptosporidium spp. from rat and mice

Biography:
Abstract:
Present study contracts with is a zoonotic intestinal protozoan parasite with public health importance. Research was aimed to determine the prevalence of Cryptosporidium in rats/mice and to assess the potential role of rodents as a source for human and animal cryptosporidiosis. A total of 49 faecal samples from field rats, tree rats, house mice and wetland rats were collected from Chittagong, Bangladesh during the period from February to July, 2017. Initial identification of Cryptosporidium spp., was carried out on stool samples by Ziehl-Neelsen (Z-N) acid fast staining method and found prevalence of 4.08%. DNA was extracted from Z-N positive and few other suspected samples using commercially available stool DNA isolation kit. Nested PCR was done to amplify 581 bp of 18S rRNA gene with the use of 1% agarose gel electrophoresis for PCR amplified products. Cryptosporidium spp., was confirmed in three samples by PCR with prevalence of 6.12%. The results of this research give an idea that rodents may act as reservoirs for zoonotic intestinal protozoan parasites and should be considered important to public health.
Anthony Wovisike Umetor
University of South Africa South Africa
Title: The church and Traditional Birth Attendants (TBAs) as twin pathways to delayed HIV testing of pregnant women in rural Nigeria

Biography:
Abstract:
Sarfraz Khan
Quaid-i-Azam University Pakistan
Title: Living with, living apart: Stigmatization of HIV/AIDS patients in Pakistan
Time : 15:05-15:25

Biography:
Abstract:
The main objective of the current research was to understand the level of stigmatization faced by HIV/AIDs positive patients in the twin cities (Islamabad and Rawalpindi) in Pakistan. The panacea of a smooth and comfortable society lies upon awareness and understanding of certain phenomenon; which forces others to discriminate people on the basis of stereotypes. In order to shape this strategy a primary area of focus is to provide the awareness regarding the death-defying diseases; like HIV/AIDS. The importance of providing information about this precarious disease is to eradicate the stigmatization done with HIV positive patients. It is very necessary to minimize this stigmatization as it hinders the process of treatment and proper care. The present study focused to understand the levels of stigmatization, its various dimensions and impacts on the HIV positive patients’ lives who were presently admitted in Islamabad and Rawalpindi hospitals in Pakistan. The current research was mainly conducted by using anthropological research methods such as: key informating, in-depth interviews and focus group discussions. Purposive sampling technique was used for the selection of the respondents. The patients currently diagnosed with HIV/AIDs were selected from the two hospitals (Rehabilitation Center and Pakistan Institute of Medical Sciences) in the twin cities. The results show that the majority of the HIV positive patients were stigmatized by their family members as well as the relatives and others which directly influence their health. The research could be helpful in devising policies regarding the inclusion of HIV/AIDS patients to the mainstream of the society as it indicated that in most of the cases these were the close family members and colleagues who stigmatized the patients.

Biography:
Abstract:
Zinat Mohebbi
Shiraz University of Medical Sciences Iran